forecast

Aging Population Drives Long-Term Pharma R&D Growth

Pharmaceutical R&D spending should grow over the long term because of rising healthcare demand from aging populations, with the WHO projecting the population over 60 to nearly double by 2050, which is a structural tailwind for Agilent.

forecastpending

Speaker

Marc

Evidence Quote

“Things like that are just going to drive healthcare spend, in our opinion, in one direction. And that's a tailwind for Agilent.”

Source

Agilent: Back To The Lab— Business Breakdowns
Created: 11/12/2026, 11:55:35 AM

Your notes

Loading notes...